The Efficacy and Safety of Combining Probiotic VSL#3 With Vedolizumab for the Treatment of Moderate Ulcerative Colitis

NCT06609447 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DIETARY_SUPPLEMENT: VSL#3
DIETARY_SUPPLEMENT: Placebo
DRUG: Vedolizumab

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University